Finn Larsen

Title: Finn Larsen: Innovator in Pharmaceutical Compositions

Introduction

Finn Larsen is a notable inventor based in Hawick, GB. He has made significant contributions to the field of pharmaceutical compositions, holding a total of 7 patents. His work focuses on innovative solutions that enhance the stability and effectiveness of various compounds.

Latest Patents

Among his latest patents is the "Reconstitutable teverelix-TFA composition." This invention relates to a stable composition that maintains its integrity during storage at temperatures around 2-8° C. Upon reconstitution, a precise amount of trifluoroacetate can be added to achieve the desired molar ratio, resulting in a fluid, milky microcrystalline aqueous teverelix-TFA suspension. Another significant patent is for a "Method of preparing a gelling agent, the gelling agent obtained thereby, and the use of said gelling agent." This method involves adding ethylcellulose to a mixture of propyleneglycol laurate and propyleneglycol isostearate at elevated temperatures. The process is designed to be simpler, less energy-consuming, and cost-effective, producing a gelling agent suitable for cosmetic and pharmaceutical applications.

Career Highlights

Finn Larsen has worked with several companies throughout his career, including Viramal Limited and S-Biotek A/S. His experience in these organizations has contributed to his expertise in developing innovative pharmaceutical solutions.

Collaborations

Some of his notable coworkers include Oliver Bates and Brian Malm. Their collaboration has likely played a role in advancing the projects they have worked on together.

Conclusion

Finn Larsen's contributions to the field of pharmaceutical compositions demonstrate his commitment to innovation and improvement in drug formulation. His patents reflect a deep understanding of the complexities involved in creating effective and stable pharmaceutical products.